Assessment of Cognitive and Functional Impairment in Older Patients After ERCP



Status:Enrolling by invitation
Conditions:Cognitive Studies, Cognitive Studies
Therapuetic Areas:Psychiatry / Psychology
Healthy:No
Age Range:60 - Any
Updated:2/17/2019
Start Date:February 8, 2019
End Date:June 2021

Use our guide to learn which trials are right for you!

Assessment of Cognitive and Functional Impairment of Older Patients After Endoscopic Retrograde Cholangiopancreatography (ERCP) and Endoscopic Ultrasound

Endoscopic retrograde cholangiopancreatography (ERCP) is an interventional endoscopy
procedure utilized in the therapeutic management of pancreatobiliary diseases including
gallstones, bile duct strictures, leaks and infections, pancreatitis, and cancers of the bile
duct or pancreas. ERCP is classified as a high risk procedure. Potential adverse events
directly attributable to the technical aspects of ERCP include pancreatitis, hemorrhage,
infection, and bowel wall perforation. Other potential adverse events of ERCP may be less
apparent and/or unknown, such as risk of neurocognitive dysfunction. Overall, neurocognitive
dysfunction after medical procedures impacts quality of life, functional disability,
depression, and caregiver and societal burden.

The prevalence of postoperative neurocognitive dysfunction and disability following
interventional endoscopy procedures such as ERCP has not been reported. This prospective
observational study is designed to assess the prevalence of cognitive impairment and
functional disability after ERCP and endoscopic ultrasound (EUS) procedures in older
patients, and to assess whether specific patient and/or procedural factors are associated
with increased risk of adverse outcomes.


Inclusion Criteria:

- Adults aged 60 years or older

- Scheduled to undergo outpatient ERCP and/or EUS at Vanderbilt University Medical
Center (VUMC)

Exclusion Criteria:

- Age <60 years

- Inpatient status at the time of ERCP/EUS

- Documented history of dementia

- Inability to provide informed consent for study participation, implying baseline
neurocognitive dysfunction

- Blind, deaf, or unable to speak English, as these conditions would preclude our
ability to perform assessments.

- No access to a telephone to permit pre-procedure and 3 month post-procedure
neurocognitive assessment
We found this trial at
1
site
1211 Medical Center Dr
Nashville, Tennessee 37232
(615) 322-5000
Vanderbilt Univ Med Ctr Vanderbilt University Medical Center (VUMC) is a comprehensive healthcare facility dedicated...
?
mi
from
Nashville, TN
Click here to add this to my saved trials